Camber Launches Generic Mepron®
Piscataway, NJ, October 12, 2018– Camber Pharmaceuticals is pleased to announce the addition of Atovaquone Oral Solution to our growing portfolio of products.
Atovaquone Oral Solution is the generic version of Mepron ®. Atovaquone is used to treat or prevent pneumonia caused by a fungal infection called Pneumocystis carinii.
Atovaquone Oral Solution is available in 750 mg/5 mL bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






